Nakia Johnson, MHS, is a seasoned professional in clinical study management, currently serving as the Director of Study Management at Pfizer since 2024. Prior to this, Nakia held various significant positions, including Associate Director of Study Management at Merck and Senior Clinical Protocol Manager at Bristol-Myers Squibb from 2010 to 2020. They also contributed as the RCTO Molecule Lead at Seagen from 2022 to 2024. Nakia earned a Master of Health Science degree from Lincoln University between 2009 and 2011.
This person is not in the org chart
This person is not in any teams
This person is not in any offices